New online program targets depression and fatigue in black breast cancer survivors
NCT ID NCT07208084
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an online group program called Project SOAR Awakenings for Black American women diagnosed with breast cancer. The program uses small-group video chats to discuss culturally relevant topics and promote well-being. Researchers will compare participants' depression, fatigue, and overall well-being to a group that receives self-guided materials. The trial aims to enroll 90 women and track results over three months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Project SOAR Awakenings online group discussions
- What this could lead to
- If it works, this could offer a culturally tailored way to improve mood, energy, and well-being for Black American women coping with breast cancer.
- What could go wrong
- This is a small, early-stage behavioral study with 90 participants. The intervention is short-term, and benefits may not last or apply to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * identifying as a woman at least 18 years of age (not limited to cisgender Black American women); * identifying as Black (African) American; * diagnosed with breast cancer of any stage and any diagnosis duration; * able to speak and read English; * residing in the United States; * access to the internet/Zoom. Exclusion Criteria: * men diagnosed with breast cancer, * non-English speaker * nonresident of the United States * no internet access
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UCLA
RECRUITINGLos Angeles, California, 90095-1563, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?